A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics
N. Iwamoto, Y. Koguchi, K. Yokoyama, A. Hamada, A. Yonezawa, B. D. Piening, E. Tran, B. A. Fox, W. L. Redmond, T. Shimada
This paper introduces a rapid and universal LC-MS-based platform for quantifying monoclonal antibodies, offering a scalable alternative to traditional ligand binding assays.
bioRxiv · Apr 22, 2022Immunology